| Date | Time | Source | Headline | Symbol | Company |
| 07/17/2024 | 5:00PM | iHub Newswire | FeaturedNightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com | | |
| 09/11/2009 | 6:01AM | Marketwired | TheFortuneFinancial.com Free Market Research on CDNS, ERIC, ISIL, AMLN, JDSU and FNFG | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/10/2009 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/10/2009 | 3:33PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/08/2009 | 11:32AM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/03/2009 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/28/2009 | 6:42AM | Marketwired | AnalystChoice.com Brings You the Best Complimentary Research Report on AMLN, NVAX, PCLN, NITE, QCOM and STEC | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/24/2009 | 7:45AM | PR Newswire (US) | Amylin Pharmaceuticals Board of Directors Elects Paulo F. Costa Chairman of the Board | NASDAQ:AMLN | |
| 08/07/2009 | 4:26PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/06/2009 | 8:28AM | Dow Jones News | Novo Nordisk CEO: Positive Victoza Reception In Europe | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 07/21/2009 | 5:20PM | Dow Jones News | Amylin 2Q Loss Narrows On Cost-Cutting; Byetta Sales Slip | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 07/21/2009 | 4:42PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/21/2009 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Second Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/21/2009 | 5:41AM | Marketwired | RothmanResearch.com Stock Review for UTIW, MESA, PFCB, AMLN, COST and JRCC | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/20/2009 | 4:14PM | PR Newswire (US) | Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study | NASDAQ:AMLN | |
| 07/14/2009 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Second Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/09/2009 | 6:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/09/2009 | 6:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/09/2009 | 6:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/09/2009 | 6:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/09/2009 | 6:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/09/2009 | 6:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/09/2009 | 7:45AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatm | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/07/2009 | 4:05PM | PR Newswire (US) | New Drug Application for Exenatide Once Weekly Accepted for Review by FDA | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/07/2009 | 8:50AM | Marketwired | RothmanResearch.com Stock Review for ASML, RFMD, MYGN, AMLN, EGLE and CENX | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/03/2009 | 7:01AM | Dow Jones News | UPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU Approval | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 07/03/2009 | 6:06AM | Dow Jones News | Novo Nordisk's Victoza To Reach Market In A Few Weeks - CSO | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 06/29/2009 | 1:33PM | PR Newswire (US) | InvestorSoup.com Issues Stock Alerts on Money Movers: Amylin, Illinois Tool Works, Fairpoint Communications, Sprint, Apple and C | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/19/2009 | 5:02PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/19/2009 | 7:59AM | Marketwired | WallStSense.com Fundamental & Technical Coverage of ATML, UTIW, AMLN and RFMD | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |